G 2/21: how to support inventive steps in patentability

Post-published evidence can be crucial to establishing patentability. G 2/21, the European Patent Office (EPO)’s referral to the Enlarged Board of Appeal (EBA) on the question of whether post-published evidence can be used to support the concept of “inventive step”.

Already registered?

For multi-user price options, or to check if your company has an existing subscription that we can add you to for FREE, please email Adrian Tapping at atapping@newtonmedia.co.uk

More on this story

Biotech

10x Genomics wins latest round in Parse patent dispute

3 September 2026 Turnaround for 10x after Federal Circuit setback as Delaware jury finds Qiagen-owned Parse infringed three patents covering single-cell sequencing technology.

MedTech

Sun Pharma import ban back in force after Squires intervention

3 September 2026 A decision at the USPTO has cleared the way for renewed enforcement in the drugmaker’s dispute over light-based dermatology tech.

Careers

White & Case life sciences co-leader moves firms

2 September 2026 The senior transactions specialist brings experience advising pharmaceutical, biotechnology and technology companies on strategic alliances, licensing, M&A and cross-border transactions.

More features

Abbott fends off Chinese rival’s patent challenge at UPC

The ‘Triple Point’ professional: Why patent success requires science, law, and technology

Reading Stief, Haedicke and Wünsche, with the memory of a decade fought in Germany

The UPC plugs another gap in its procedural rulebook

European court strikes down hearing aid sensor patent

‘Engagement and collaboration’: New IP Federation president builds on strong foundations

Pharmascience v Janssen: Canada court updates methods of medical treatment protection

UPC upholds injunction in Invisalign maker’s software dispute with rival

G 2/21: how to support inventive steps in patentability

More on this story

Editor's picks

Editor's picks

More features